The number of individuals diagnosed with dementia in the United States is expected to rise sharply over the next several decades, posing significant challenges to a healthcare system already under strain. A recent study published in JAMA Neurology projects that the annual incidence of new dementia cases worldwide will more than double, increasing from 11.4 million in 2023 to 24.7 million by 2050. In the U.S., new dementia diagnoses are estimated to nearly double from 514,000 in 2020 to approximately 1 million by 2060.

Several factors contribute to this projected increase, including rising life expectancy, which results in more people reaching age groups where dementia is most prevalent. Additionally, demographic shifts such as the near doubling of the Hispanic population between 2000 and 2024— a group 1.5 times more likely to develop dementia than non-Hispanic white individuals — contribute to the anticipated growth, according to data from the Alzheimer’s Association.

Efforts to address this growing demand are complicated by a shortage of specialized healthcare workers. The number of geriatricians in the U.S. has declined from 10,270 in 2000 to 7,413 in 2022, partly due to lower compensation and less interest among medical trainees. Nursing homes and home care services face critical staffing challenges as well. A 2024 report by the American Health Care Association found that nearly all facilities experienced difficulties recruiting staff, citing a lack of qualified or interested candidates. Consequently, about half of nursing homes have limited new resident admissions.

Low wages and the physically and emotionally demanding nature of caregiving jobs contribute to workforce shortages. According to the Bureau of Labor Statistics, median hourly wages in May 2025 were $19 for nursing assistants and $17 for home health aides, despite projected growth in these roles by 48% and 42%, respectively, between 2020 and 2035. Experts emphasize that the low retention rates among direct care workers exacerbate the problem, as these roles require hands-on support that cannot be automated.

Policy decisions have also influenced the landscape of dementia care. The Trump administration’s passage of the One Big Beautiful Bill Act in 2025 included nearly $1 trillion in Medicaid cuts over a decade. Medicaid finances more than half of U.S. long-term care expenditures. Experts warn that such reductions complicate access to essential services like home care and respite care for Medicaid-eligible dementia patients.

In response to staffing shortages, some states have introduced incentives. For example, South Carolina offers loan forgiveness programs for physicians specializing in geriatrics who commit to practicing in the state for five years. Nearly half of states reported incentive payments aimed at recruiting or retaining Medicaid home care workers in 2025.

Despite these challenges, recent advances offer some hope. The U.S. Food and Drug Administration has approved two drugs, Kisunla and Leqembi, that modestly slow cognitive decline in early-stage Alzheimer’s patients. Diagnostic tools, including newly approved blood tests, enhance early detection and risk prediction, though these treatments may increase healthcare system costs.

Researchers stress the importance of prevention and strengthening care infrastructure in tandem with medical innovation. “We have a real opportunity to reduce dementia risk through better cardiovascular health and physical activity,” said Jordan Weiss, assistant professor at NYU Langone’s Optimal Aging Institute. Experts agree that building a healthcare system capable of meeting the growing demands of dementia care is imperative, as a definitive cure remains elusive.